Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

Abstract PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer (PCa), but its clinical use was promptly extended to detection, staging and therapy response assessment. The expanding use of PSMA PET worldwide has also revealed PSMA ligand uptake in diverse nonprosta...

Full description

Bibliographic Details
Main Authors: Felipe de Galiza Barbosa, Marcelo Araujo Queiroz, Rafael Fernandes Nunes, Larissa Bastos Costa, Elaine Caroline Zaniboni, José Flavio Gomes Marin, Giovanni Guido Cerri, Carlos Alberto Buchpiguel
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Cancer Imaging
Subjects:
Prostate cancer
Positron emission tomography
(68)Ga-PSMA
Online Access:http://link.springer.com/article/10.1186/s40644-020-00300-7

Internet

http://link.springer.com/article/10.1186/s40644-020-00300-7

Similar Items